Evidence map›Paper›PMID 22223429›Full record

ArticleCirculation2012

Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.

Csaba P Kovesdy, Evan H Lott, Jun Ling Lu, Sandra M Malakauskas, Jennie Z Ma, Miklos Z Molnar, Kamyar Kalantar-Zadeh

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Circulation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06675591 (Mortality and Neurologic Complications Associated With Rapid Versus Slow Correction of Hyponatremia), which is not on this map. Cited by 131 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 3 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06675591 completednot on this mapstarted 2024, after this paper: background citation

Mortality and Neurologic Complications Associated With Rapid Versus Slow Correction of Hyponatremia

TypeobservationalSponsorHospital Italiano de Buenos AiresRan2024 to 2024Enrolled2,037ConditionsHyponatremia, Hospitalisation, Mortality, SEVERE HYPONATREMIAArmsRapid sodium correction, Slow sodium correction
3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 3 syntheses or guidelines pooled it, 302 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. An organic artificial cardiomyocyte.Nature communications · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The biology of water homeostasis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Hyponatremia unleashes neutrophil extracellular traps elevating life-threatening pulmonary embolism risk.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Csaba P KovesdyDivision of Nephrology, Salem Veterans Affairs Medical Center, 1970 Roanoke Blvd, Salem, VA 24153, USA. csaba.kovesdy@va.gov
Evan H Lott
Jun Ling Lu
Sandra M Malakauskas
Jennie Z Ma
Miklos Z Molnar
Kamyar Kalantar-Zadeh
University of Virginia · USSemmelweis University · HU

Funding

Examining Racial and Cardiovascular Paradoxes in Chronic Kidney DiseaseR01DK078106 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KALANTAR-ZADEH, KAMYAR · 2007 to 2011
$1.1M
NIDDK NIH HHS 1R01DK078106-01NIDDK NIH HHS R01 DK078106
6 · The paper itself

Abstract

backgroundHyponatremia is common in patients with conditions such as congestive heart failure and is associated with increased mortality in hospitalized patients. Congestive heart failure is common in patients with chronic kidney disease, but the association of serum sodium concentration with mortality in such patients is not well characterized. METHODS AND

resultsWe examined the association of serum sodium concentration with all-cause mortality in a nationally representative cohort of 655 493 US veterans with non-dialysis-dependent chronic kidney disease (95 961 [15%] of them with congestive heart failure). Associations were examined in time-dependent Cox models with adjustment for potential confounders. During a median follow-up of 5.5 years, a total of 193 956 patients died (mortality rate, 62.5/1000 patient-years; 95% confidence interval, 62.2-62.8). The association of serum sodium level with mortality was U-shaped, with the lowest mortality seen in patients with sodium level of 140 mEq/L and with both lower and higher levels showing significant associations with increased mortality. Patients with serum sodium levels of <130, 130 to 135.9, 145.1 to 150, and ≥150 mEq/L compared with 136 to 145 mEq/L had multivariable-adjusted mortality hazard ratios (95% confidence interval) of 1.93 (1.83-2.03), 1.28 (1.26-1.30), 1.33 (1.28-1.38), and 1.56 (1.33-1.83) (P<0.001 for all). The associations remained consistent in subgroups of patients with and without congestive heart failure.

conclusionsBoth lower and higher serum sodium levels are independently associated with higher mortality in patients with non-dialysis-dependent chronic kidney disease, irrespective of the presence or absence of congestive heart failure.

Indexed as

AgedAged, 80 and overBiomarkersChronic DiseaseComorbidityFemaleFollow-Up StudiesHeart FailureHumansHypernatremiaHyponatremiaIncidenceKidney DiseasesMaleMiddle AgedPredictive Value of TestsBiomarkersSodium

Identifiers

PMID22223429
PMCPMC3294276
OpenAlexW2034129937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.